Posluma is a PSMA-targeted PET imaging agent used in prostate cancer. It helps doctors detect and locate primary and metastatic prostate tumors more accurately using a novel radiohybrid compound.
To Get Full Access :
To Get Full Access :
Posluma is a PSMA-targeted PET imaging agent used in prostate cancer. It helps doctors detect and locate primary and metastatic prostate tumors more accurately using a novel radiohybrid compound.
The information outlined in the molecule details section below would help you evaluate Para IV filing opportunities early to secure a first-to-file advantage.
For full access Sign-up / Sign-in using below Methods:
By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.
